Cargando…
P978: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA: INTERIM ANALYSIS OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429055/ http://dx.doi.org/10.1097/01.HS9.0000846780.34380.00 |
| _version_ | 1784779313493573632 |
|---|---|
| author | Zhuang, Z. Tian, Y. Yu, H. Shi, L. Tian, W.-W. Liu, Q. Zou, D. Dong, F. Ma, Y. Feng, R. Liu, S. Liu, H. Jing, H. Sun, W. Ma, L.-M. Bao, L. Fu, R. Wu, Y. Chen, W. Zhuang, J. |
| author_facet | Zhuang, Z. Tian, Y. Yu, H. Shi, L. Tian, W.-W. Liu, Q. Zou, D. Dong, F. Ma, Y. Feng, R. Liu, S. Liu, H. Jing, H. Sun, W. Ma, L.-M. Bao, L. Fu, R. Wu, Y. Chen, W. Zhuang, J. |
| author_sort | Zhuang, Z. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429055 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94290552022-08-31 P978: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA: INTERIM ANALYSIS OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA Zhuang, Z. Tian, Y. Yu, H. Shi, L. Tian, W.-W. Liu, Q. Zou, D. Dong, F. Ma, Y. Feng, R. Liu, S. Liu, H. Jing, H. Sun, W. Ma, L.-M. Bao, L. Fu, R. Wu, Y. Chen, W. Zhuang, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429055/ http://dx.doi.org/10.1097/01.HS9.0000846780.34380.00 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhuang, Z. Tian, Y. Yu, H. Shi, L. Tian, W.-W. Liu, Q. Zou, D. Dong, F. Ma, Y. Feng, R. Liu, S. Liu, H. Jing, H. Sun, W. Ma, L.-M. Bao, L. Fu, R. Wu, Y. Chen, W. Zhuang, J. P978: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA: INTERIM ANALYSIS OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA |
| title | P978: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA: INTERIM ANALYSIS OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA |
| title_full | P978: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA: INTERIM ANALYSIS OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA |
| title_fullStr | P978: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA: INTERIM ANALYSIS OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA |
| title_full_unstemmed | P978: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA: INTERIM ANALYSIS OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA |
| title_short | P978: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA: INTERIM ANALYSIS OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA |
| title_sort | p978: ixazomib versus lenalidomide or ixazomib and lenalidomide combination as maintenance regimen for patients with multiple myeloma: interim analysis of a multi-center prospective study in china |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429055/ http://dx.doi.org/10.1097/01.HS9.0000846780.34380.00 |
| work_keys_str_mv | AT zhuangz p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT tiany p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT yuh p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT shil p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT tianww p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT liuq p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT zoud p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT dongf p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT may p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT fengr p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT lius p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT liuh p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT jingh p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT sunw p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT malm p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT baol p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT fur p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT wuy p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT chenw p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina AT zhuangj p978ixazomibversuslenalidomideorixazomibandlenalidomidecombinationasmaintenanceregimenforpatientswithmultiplemyelomainterimanalysisofamulticenterprospectivestudyinchina |